Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer Cells
Open Access
- 1 October 2002
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 277 (43), 40950-40957
- https://doi.org/10.1074/jbc.m202333200
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell MigrationJournal of Biological Chemistry, 2002
- Plasminogen Activator Inhibitor Type 1 Promotes the Self-association of Vitronectin into Complexes Exhibiting Altered Incorporation into the Extracellular MatrixJournal of Biological Chemistry, 2002
- Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell PopulationsThe American Journal of Pathology, 2002
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- Urinary-type Plasminogen Activator (uPA) Expression and uPA Receptor Localization Are Regulated by α3β1Integrin in Oral KeratinocytesPublished by Elsevier BV ,2000
- Partitioning of Serpin-Proteinase Reactions between Stable Inhibition and Substrate Cleavage Is Regulated by the Rate of Serpin Reactive Center Loop Insertion into β-Sheet APublished by Elsevier BV ,2000
- Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1International Journal of Cancer, 1999
- Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCRBreast Cancer Research and Treatment, 1996
- Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cellsInternational Journal of Cancer, 1995
- Modulation of protein C inhibitor activityBlood Coagulation & Fibrinolysis, 1994